Mitochondrial dynamics, mitophagy and cardiovascular disease
- PMID: 26537557
- PMCID: PMC5341713
- DOI: 10.1113/JP271301
Mitochondrial dynamics, mitophagy and cardiovascular disease
Abstract
Cardiac hypertrophy is often initiated as an adaptive response to haemodynamic stress or myocardial injury, and allows the heart to meet an increased demand for oxygen. Although initially beneficial, hypertrophy can ultimately contribute to the progression of cardiac disease, leading to an increase in interstitial fibrosis and a decrease in ventricular function. Metabolic changes have emerged as key mechanisms involved in the development and progression of pathological remodelling. As the myocardium is a highly oxidative tissue, mitochondria play a central role in maintaining optimal performance of the heart. 'Mitochondrial dynamics', the processes of mitochondrial fusion, fission, biogenesis and mitophagy that determine mitochondrial morphology, quality and abundance have recently been implicated in cardiovascular disease. Studies link mitochondrial dynamics to the balance between energy demand and nutrient supply, suggesting that changes in mitochondrial morphology may act as a mechanism for bioenergetic adaptation during cardiac pathological remodelling. Another critical function of mitochondrial dynamics is the removal of damaged and dysfunctional mitochondria through mitophagy, which is dependent on the fission/fusion cycle. In this article, we discuss the latest findings regarding the impact of mitochondrial dynamics and mitophagy on the development and progression of cardiovascular pathologies, including diabetic cardiomyopathy, atherosclerosis, damage from ischaemia-reperfusion, cardiac hypertrophy and decompensated heart failure. We will address the ability of mitochondrial fusion and fission to impact all cell types within the myocardium, including cardiac myocytes, cardiac fibroblasts and vascular smooth muscle cells. Finally, we will discuss how these findings can be applied to improve the treatment and prevention of cardiovascular diseases.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5341713/bin/TJP-594-509-g002.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5341713/bin/TJP-594-509-g003.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5341713/bin/TJP-594-509-g004.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/5341713/bin/TJP-594-509-g005.gif)
Similar articles
-
Emerging role of mitophagy in cardiovascular physiology and pathology.Mol Aspects Med. 2020 Feb;71:100822. doi: 10.1016/j.mam.2019.09.006. Epub 2019 Oct 3. Mol Aspects Med. 2020. PMID: 31587811 Review.
-
Mitophagy as a Protective Mechanism against Myocardial Stress.Compr Physiol. 2017 Sep 12;7(4):1407-1424. doi: 10.1002/cphy.c170005. Compr Physiol. 2017. PMID: 28915329 Review.
-
Molecular regulation of mitochondrial dynamics in cardiac disease.Biochim Biophys Acta Mol Cell Res. 2017 Jul;1864(7):1260-1273. doi: 10.1016/j.bbamcr.2017.03.006. Epub 2017 Mar 22. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28342806 Review.
-
Agent-Based Modeling of Mitochondria Links Sub-Cellular Dynamics to Cellular Homeostasis and Heterogeneity.PLoS One. 2017 Jan 6;12(1):e0168198. doi: 10.1371/journal.pone.0168198. eCollection 2017. PLoS One. 2017. PMID: 28060865 Free PMC article.
-
Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system.J Mol Cell Cardiol. 2015 Jan;78:116-22. doi: 10.1016/j.yjmcc.2014.09.019. Epub 2014 Oct 7. J Mol Cell Cardiol. 2015. PMID: 25305175 Free PMC article. Review.
Cited by
-
Pgam5 aggravates hyperglycemia-induced myocardial dysfunction through disrupting Phb2-dependent mitochondrial dynamics.Int J Med Sci. 2024 May 5;21(7):1194-1203. doi: 10.7150/ijms.92872. eCollection 2024. Int J Med Sci. 2024. PMID: 38818468 Free PMC article.
-
Mitochondrial quality control in human health and disease.Mil Med Res. 2024 May 29;11(1):32. doi: 10.1186/s40779-024-00536-5. Mil Med Res. 2024. PMID: 38812059 Free PMC article. Review.
-
Sevoflurane postconditioning attenuates cardiomyocytes hypoxia/reoxygenation injury via PI3K/AKT pathway mediated HIF-1α to regulate the mitochondrial dynamic balance.BMC Cardiovasc Disord. 2024 May 29;24(1):280. doi: 10.1186/s12872-024-03868-1. BMC Cardiovasc Disord. 2024. PMID: 38811893 Free PMC article.
-
DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure.Signal Transduct Target Ther. 2024 May 24;9(1):127. doi: 10.1038/s41392-024-01831-2. Signal Transduct Target Ther. 2024. PMID: 38782919 Free PMC article.
-
Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies.Int J Med Sci. 2024 Mar 11;21(5):809-816. doi: 10.7150/ijms.94485. eCollection 2024. Int J Med Sci. 2024. PMID: 38617011 Free PMC article. Review.
References
-
- Abouhamed M, Reichenberg S, Robenek H & Plenz G (2003). Tropomyosin 4 expression is enhanced in dedifferentiating smooth muscle cells in vitro and during atherogenesis. Eur J Cell Biol 82, 473–482. - PubMed
-
- Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, Osame M & Tanaka H (1995). Cardiac involvement in mitochondrial diseases: A study on 17 patients with documented mitochondrial DNA defects. Circulation 91, 955–961. - PubMed
-
- Ashrafian H , Docherty L, Leo V, Towlson C, Neilan M, Steeples V, Lygate CA, Hough T, Townsend S, Williams D, Wells S, Norris D, Glyn‐Jones S, Land J, Barbaric I, Lalanne Z, Denny P, Szumska D, Bhattacharya S, Griffin JL, Hargreaves I, Fernandez‐Fuentes N, Cheeseman M, Watkins H & Dear TN (2010). A mutation in the mitochondrial fission gene Dnm1l leads to cardiomyopathy. PLoS Genet 6, e1001000. - PMC - PubMed
-
- Ballinger SW, Patterson C, Knight‐Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K & Runge MS (2002). Mitochondrial integrity and function in atherogenesis. Circulation 106, 544–549. - PubMed
-
- Barry SP, Davidson SM & Townsend PA (2008). Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 40, 2023–2039. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials